06-Sep-2010 - Aurobindo Pharma is to supply AstraZeneca with solid dosage and sterile generic products for sale in emerging products.
01-Sep-2010 - RecipharmCobra Biologics has received US and EU patent protection for an antibiotic resistance gene-free plasmid maintenance technology it claims can boost biomanufacturing yields.
30-Aug-2010 - Lonza buys viral-based biologics maker Vivante GMP Solutions to broaden custom manufacturing offering.
26-Aug-2010 - A fully-equipped disposable manufacturing facility has been added to CMC Biologic’s Seattle, WA site, as the first stage of a major expansion plan.
26-Aug-2010 - Mtech Bioprocess is to double scale-up square footage and staff to support Maryland, US biotechs’ non-GMP production work.
24-Aug-2010 - The FDA has approved Alexion Pharmaceuticals’ Rhode Island, US plant for commercial supply of Soliris (eculizumab), giving the biopharm a second source.
23-Aug-2010 - Chemir Analytical Services launches custom synthesis service for organic molecules for drug R&D, aimed at small pharma companies with rush or emergency projects.
18-Aug-2010 - Aesica will build a “high containment” manufacturing plant to expand its high potency drug formulation capabilities in line with growing demand.
17-Aug-2010 - Patheon is partnering with TraceLink to increase manufacturing efficiencies through closer integration and collaboration with clients.
11-Aug-2010 - Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”
10-Aug-2010 - Label manufacturer ATL has licensed anti-counterfeiting technologies from Document Security Systems (DSS) to meet growing demand from pharma clients.
10-Aug-2010 - Lower overseas demand from key customers hurt fine chemicals maker Synthetech in first quarter fiscal 2011, continuing the decline seen in the previous financial year
05-Aug-2010 - Cel-Sci’s recently opened “Cold fill” facility has passed its first manufacturing test by completing filling of a batch of the candidate head and neck cancer drug Multikine for a late-stage trial.
05-Aug-2010 - Ampac Fine Chemicals posted a 28 per cent jump in revenues in the third quarter but this was offset by manufacturing inefficiencies and validation costs.
05-Aug-2010 - Norwich Pharmaceuticals has added development-stage drug production to its offering with new dedicated non-GMP capacity at its New York plant.
04-Aug-2010 - In the first of a series of special in-pharmatechnologist podcasts Kate Wilber, Image Solutions’ (ISI) director of regulatory Services, Europe discusses the emerging trends in BPO and talks about how it can benefit drugmakers.
04-Aug-2010 - High tech packaging sales and revenue from acquired delivery businesses drive West Pharmaceutical Services growth in second quarter, but US firm cuts guidance.
04-Aug-2010 - Pfenex has won a US federal contract to use its expression technology for the rapid, cost-effective production of “unprecedented” amounts of anthrax vaccine.
03-Aug-2010 - Bilcare to buy Ineos’ rigid polymer films business for €100m ($132m) to improve access to pharmaceutical packaging customers worldwide.
03-Aug-2010 - Greater recognition of toxicity risks of HPAPIs and continued growth of oncology sector are driving drug industry demand for safe manufacturing capacity says US fine molecules firm SAFC Pharma.
02-Aug-2010 - Recently-acquired Italian R&D facility helps Aptuit win new contract after local neuroscience-focused developer Siena Biotech names the CMO as “supplier of choice.”
29-Jul-2010 - Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact on contract research organizations (CRO).
27-Jul-2010 - Colorcon will buy Indian group Pharmaceuitcal Coatings to expand both its tablet film coating business and presence in “rapidly growing” pharmaceutical market.
22-Jul-2010 - Indian contractor Terrene Pharma has filed a DMF for hard gelatin capsules with the US FDA, signalling its intention to expand in the world’s most lucrative drug market.
21-Jul-2010 - CROs MDCI and CDSS have partnered to expand their geographic reach and drive growth through cooperation.